NO951608D0 - Use of BHAP Compounds in Combination with Other Non-Nucleoside Reverse Transcriptase Inhibitors for the Treatment of HIV Infection - Google Patents

Use of BHAP Compounds in Combination with Other Non-Nucleoside Reverse Transcriptase Inhibitors for the Treatment of HIV Infection

Info

Publication number
NO951608D0
NO951608D0 NO951608A NO951608A NO951608D0 NO 951608 D0 NO951608 D0 NO 951608D0 NO 951608 A NO951608 A NO 951608A NO 951608 A NO951608 A NO 951608A NO 951608 D0 NO951608 D0 NO 951608D0
Authority
NO
Norway
Prior art keywords
bhap
compounds
treatment
combination
reverse transcriptase
Prior art date
Application number
NO951608A
Other languages
Norwegian (no)
Other versions
NO951608L (en
Inventor
William Gary Tarpley
Thomas Jerome Dueweke
Donald Herman M D Batts
Original Assignee
Upjohn Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Upjohn Co filed Critical Upjohn Co
Publication of NO951608D0 publication Critical patent/NO951608D0/en
Publication of NO951608L publication Critical patent/NO951608L/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO951608A 1992-10-28 1995-04-27 Use of BHAP Compounds in Combination with Other Non-Nucleoside Reverse Transcriptase Inhibitors for the Treatment of HIV Infection NO951608L (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US96763992A 1992-10-28 1992-10-28
US1711993A 1993-02-12 1993-02-12
PCT/US1993/008354 WO1994009781A1 (en) 1992-10-28 1993-09-10 Use of bhap compounds in combination with other non-nucleoside reverse transcriptase inhibitors for the treatment of hiv infection

Publications (2)

Publication Number Publication Date
NO951608D0 true NO951608D0 (en) 1995-04-27
NO951608L NO951608L (en) 1995-06-28

Family

ID=26689480

Family Applications (1)

Application Number Title Priority Date Filing Date
NO951608A NO951608L (en) 1992-10-28 1995-04-27 Use of BHAP Compounds in Combination with Other Non-Nucleoside Reverse Transcriptase Inhibitors for the Treatment of HIV Infection

Country Status (12)

Country Link
EP (1) EP0666744A1 (en)
JP (1) JPH08502745A (en)
KR (1) KR950703958A (en)
AU (1) AU4848293A (en)
CA (1) CA2145545A1 (en)
CZ (1) CZ69695A3 (en)
FI (1) FI952018A (en)
HU (1) HUT72050A (en)
MX (1) MX9306031A (en)
NO (1) NO951608L (en)
PL (1) PL308551A1 (en)
WO (1) WO1994009781A1 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW406075B (en) * 1994-12-13 2000-09-21 Upjohn Co Alkyl substituted piperidinyl and piperazinyl anti-AIDS compounds
WO2002072548A2 (en) 2001-03-09 2002-09-19 Ortho-Mcneil Pharmaceutical, Inc. Heterocyclic compounds and their use as histamine h4 ligands.
KR20050033662A (en) 2002-09-06 2005-04-12 얀센 파마슈티카 엔.브이. Heterocyclic compounds
US8541407B2 (en) 2010-03-31 2013-09-24 Arqule, Inc. Substituted benzo-pyrido-triazolo-diazepine compounds
US8569331B2 (en) 2010-11-01 2013-10-29 Arqule, Inc. Substituted benzo[f]lmidazo[1,2-d]pyrido[2,3-b][1,4]diazepine compounds

Also Published As

Publication number Publication date
CA2145545A1 (en) 1994-05-11
MX9306031A (en) 1994-04-29
HU9501218D0 (en) 1995-06-28
AU4848293A (en) 1994-05-24
KR950703958A (en) 1995-11-17
FI952018A0 (en) 1995-04-27
HUT72050A (en) 1996-03-28
WO1994009781A1 (en) 1994-05-11
FI952018A (en) 1995-04-27
JPH08502745A (en) 1996-03-26
NO951608L (en) 1995-06-28
EP0666744A1 (en) 1995-08-16
PL308551A1 (en) 1995-08-21
CZ69695A3 (en) 1995-12-13

Similar Documents

Publication Publication Date Title
FI931097A (en) LAEKEMEDEL, DERAS FRAMSTAELLNING OCH ANVAENDNING VID BEKAEMPNING AV SMAERTOR OCH / ELLER INFLAMMATIONEN HOS MAENNISKOR OCH DJUR
FI941222A (en) Non-peptidyl-type integrin inhibitors specific for the GPIIbIIIa receptor
DK0509019T3 (en) Treatment of human retroviral infections with 2 ', 3'-dideoxyinosine
PT824524E (en) SUBSTITUTED PYRIMIDINE-THIOALKYL AND ALKYLETER COMPOUNDS IN ALPHA AS VIRAL REVERSAL TRANSCRIPTASE INHIBITORS
NO953370D0 (en) Use of riluzole in the treatment of neuro-AIDS
IL99843A0 (en) Synergistic combination of hiv reverse transcriptase inhibitors
DK261490D0 (en) NEW PHARMACEUTICAL COMPOUND
OA09917A (en) Compounds for use in treating HIV infection
NO960775L (en) Use of quinoxalins in combination with protease inhibitors as a drug for the treatment of AIDS and / or HIV infections
NO951608D0 (en) Use of BHAP Compounds in Combination with Other Non-Nucleoside Reverse Transcriptase Inhibitors for the Treatment of HIV Infection
DK0458589T3 (en) Treatment of ocular hypertension with an ocular synergistic combination
FI862251A0 (en) SPIRO-IMIDAZOLIDINER SOM INHIBITORER FOER ALDOSREDUKTAS.
YU6396A (en) Combination of hiv protease inhibitor with other compounds for hiv infection treatment
DK694188A (en) APPLICATION OF ACE INHIBITOR FOR PHARMACEUTICAL PREPARATION, EV. IN COMBINATION WITH A CALCIUM CHANNEL BLOCKING AGENT
NO20002481L (en) Combination therapy for the treatment of AIDS
FI945446A (en) Use of cotine to relieve tobacco withdrawal syndrome
NO960545D0 (en) Treatment of adverse effects associated with the administration of extracellular hemoglobin
ATE75399T1 (en) THERAPEUTIC FOR TREATMENT OF STOMACH ULCERS.
MX9700036A (en) Combination therapy for hiv infection.
DK0774969T3 (en) HIV protease inhibitor combination
SU1095491A1 (en) Medicine for treating cardialgia and easy forms of heart ischemia "mebikar"
KR970703770A (en) Combination therapy for HIV infection
ATE178800T1 (en) PHARMACEUTICAL PENTAPEPTIDE COMPOSITION AND USE THEREOF
RU93054179A (en) NEW SULFONAMIDES